- .

.-. ..

2013

 () .

= .
(, )
() =
.
.

,
.



,

2-.

: (, ),
, ,
.

Kiss-peptin = (U.B.Kaiser, J Clin
Invest.2012;122(10):34673468).

 ()

(, , )

 ( )

health-7.com




-
.
,

-,
.

-
.

U.B.Kaiser, J Clin Invest.2012;122(10):34673468

 ()

(jet leg)

(, )

(, ,)




( 100 /)
(+jet-leg, c,
, ).
!
,
, , .

, , .

 ()
.

,
.
L- .


40% .
25-34 .

30-50 100 000.

 100.000

39% -
-
-- 14%
-- -7%

1/3

0.1-0.2% , .

Am J Obstet Gynecol 1972; 113:14; N Engl J Med 1977; 296:589; Clin Ther 200; 22:1085; Clin Endocrinol 1976; 5:273;
J Clin Endocrinol Metab 1976; 42:1148; J Clin Endocrinoll Metab 42: 181; J Clin Endocrinol Metab 1982; 54:869; Br Med J 1976; 1:1186;
JAMA 1976; 235:2316; Am J Cardiol 1983; 51:1466; J Clin Endocrinol Metab 1985; 60:144.

 -
10

- 0-12.5%
,

 -
10

50%
()
=
.

-

226
94/.
,
.





-
:
: , , , ,

 25-100 /

,
(50-100% )



(2)




(!)

,
-
- 3-5

, ,
200/


8-9%,

.
30%
, .




()

()
! .
,
. !


( )


- : ,
.

,
( )
(?) ( , )

, , ,
, ( ).



( (?), , )

, 6


10 %
.
30%
.




(Elms AF 2012),
(R. W. Turkington 1971), -
.
! .

 ()


1/3

/
.
.
( , ,
, , (?),
).
, (?),
.
, ,
(.. ).
-
( 25%),
!
.


-


b-
, ,
.




( 2013),

.



( ).
.
25/
1/=21,2/
, ( ).

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

:

( ).
big-big-
.
big-big-
, .
, 40% .
20%, /- 45%,
20%.
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

:hook-effect
: ,
-
= .
.

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

 500/
250/ ( 10 )
200/

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


, :



( ,
)




,
.
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


, .
:
-
- , 4
- , /
- , , ,
- 1

( , ,

, )!!!
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

:
( )
(), - +
, +
.

();
.
(
L-).
() .

-
( ).
, , ,
.
,
.
.
2 5
( ) - 67% (Colao A, N. Engl. J. Med.
2003).

, .
.
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


0,5 1 2 ( 0,5
) ( ).
0,5
. ,
1 / 0,25 2 /.
4,5 /.
2
.
>1 /.
, ,
(1 ) .
, , 24
.





( 0,25 1 )

.


( 0,25 2 )
.


1 .
1 , 1 .
,

( , ) 3 .
.

,
, .

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


2
.
=26-69%
Biswas M, 2005.Clin Endocrinol (Oxf) 63:2631 ;Kharlip J 2009 J Clin Endocrinol Metab 94:24282436

.
28%


- 3
, .
- - .
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


/
.
( , -
).

.
,
75% ,

.

.
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline


, . !

.
, ,
.
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

Corenblum B, 1993 Steril 59:671673 ; Testa G 1998 Contraception 58:6973


10%
25%, 80%

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

(50%)

.
-
.
- 2 ?
(18%
), 10%.
.
11/.

( )!
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

7 50%
.
, ,
, .
( 50 )
, .

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline




.
6000
(1).
80 ( 5 ) -
(2).
-
.
, ..
.
1 ( ).
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

1. Molitch ME 2006 EndocrinolMetab Clin North Am 35:99116, vi

2. Ono M, 2010 J Clin Endocrinol Metab 95:26722679



(
).
.
457 , ,
2,6% (1).

4,5-5% (1).

(31%) (1). .
.
,
, - .
100
,
.
- .
S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

1 Gillam MP2006 Endocr Rev 27:485534

!

.
,

! .

S. Melmed et al J Clin Endocrinol Metab, February 2011, 96(2):273288 Diagnosis and Treatment of Hyperprolactinemia: Endocr Society Clinical Practice Guideline

Results of a Single-Center Observational 10-Year Survey Study on Recurrence of

Hyperprolactinemia after Pregnancy and Lactation
R. S. Auriemma, et al. Endocrine Research 2013

10

:
: 19972008, 143 91
( 30.4 4.7 , 76 , 10 ).
6 ..
: 13 (9.1%) , 126 (88.1%) .
. 29 91 (3 ),
6 -
, 68% 60
. . 35 (38.5%)
2 , 56 (61.5%) 2 6 .
% .
:
.
68%.
.

:
(, )
.
,
,
.
().

.

( ) .

.
,
,
.
.

C !